01-07-2013 | Clinical Trial
A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer
Published in: Breast Cancer Research and Treatment | Issue 2/2013
Login to get access01-07-2013 | Clinical Trial
Published in: Breast Cancer Research and Treatment | Issue 2/2013
Login to get access